Picture of Eurobio Scientific SA logo

ALERS — Eurobio Scientific SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareAdventurousSmall CapHigh Flyer

Brief: Eurobio Scientific FY Revenue Up 220% At 189 Million Euros

Jan 25 (Reuters) - EUROBIO SCIENTIFIC SA  ALERS.PA :
    * FY REVENUE ROSE 220 PERCENT TO 189 MILLION EUR
    * MORE THAN 60% OF THESE SALES (EUR 117M) ARE RELATED TO
COVID-19
DIAGNOSTIC TESTS AND INSTRUMENTS
    * GROUP EXPECTS A VERY STRONG IMPROVEMENT IN ITS RESULTS FOR
2020
FINANCIAL YEAR
    * VERY SOLID FINANCIAL BASE WITH A CASH POSITION OF AROUND
EUR 65
MILLION AS OF DECEMBER 31, 2020, AND AROUND EUR 25 MILLION OF
OVERALL FINANCIAL DEBT
    * INCREASED VISIBILITY AND THESE STRENGTHENED RESOURCES WILL
ENABLE EUROBIO SCIENTIFIC TO ACCELERATE ITS STRATEGIC DEPLOYMENT

Source text for Eikon:  ID:nGNE9RwNmS 
Further company coverage:  ALERS.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))

Recent news on Eurobio Scientific SA

See all news